Literature DB >> 32175700

Fibroblast-specific Stat1 deletion enhances the myofibroblast phenotype during tissue repair.

Shayna C Medley1,2, Bharath H Rathnakar1, Constantin Georgescu3, Jonathan D Wren3, Lorin E Olson1,2.   

Abstract

Signal transducer and activator of transcription 1 (Stat1) is a ubiquitously expressed latent transcription factor that is activated by many cytokines and growth factors. Global Stat1 knockout mice are prone to chemical-induced lung and liver fibrosis, suggesting roles for Stat1 in tissue repair. However, the importance of Stat1 in fibroblast-mediated and vascular smooth muscle cell (VSMC)-mediated injury response has not been directly evaluated in vivo. Here, we focused on two models of tissue repair in conditional Stat1 knockout mice: excisional skin wounding in mice with Stat1 deletion in dermal fibroblasts, and carotid artery ligation in mice with global Stat1 deletion or deletion specific to VSMCs. In the skin model, dermal wounds closed at a similar rate in mice with fibroblast Stat1 deletion and controls, but collagen and α-smooth muscle actin (αSMA) expression were increased in the mutant granulation tissue. Cultured Stat1 -/- and Stat1 +/- dermal fibroblasts exhibited similar αSMA+ stress fiber assembly, collagen gel contraction, proliferation, migration, and growth factor-induced gene expression. In the artery ligation model, there was a significant increase in fibroblast-driven perivascular fibrosis when Stat1 was deleted globally. However, VSMC-driven remodeling and neointima formation were unchanged when Stat1 was deleted specifically in VSMCs. These results suggest an in vivo role for Stat1 as a suppressor of fibroblast mediated, but not VSMC mediated, injury responses, and a suppressor of the myofibroblast phenotype.
© 2020 by the Wound Healing Society.

Entities:  

Year:  2020        PMID: 32175700      PMCID: PMC7321860          DOI: 10.1111/wrr.12807

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  36 in total

1.  Loss of STAT1 from mouse mammary epithelium results in an increased Neu-induced tumor burden.

Authors:  Peter J Klover; William J Muller; Gertraud W Robinson; Ruth M Pfeiffer; Daisuke Yamaji; Lothar Hennighausen
Journal:  Neoplasia       Date:  2010-11       Impact factor: 5.715

2.  Regulation of c-myc expression by IFN-gamma through Stat1-dependent and -independent pathways.

Authors:  C V Ramana; N Grammatikakis; M Chernov; H Nguyen; K C Goh; B R Williams; G R Stark
Journal:  EMBO J       Date:  2000-01-17       Impact factor: 11.598

3.  Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

Authors:  J F Bromberg; C M Horvath; Z Wen; R D Schreiber; J E Darnell
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

4.  Interferon-gamma-mediated inhibition of serum response factor-dependent smooth muscle-specific gene expression.

Authors:  Zengdun Shi; Don C Rockey
Journal:  J Biol Chem       Date:  2010-08-04       Impact factor: 5.157

5.  Impairment of mycobacterial but not viral immunity by a germline human STAT1 mutation.

Authors:  S Dupuis; C Dargemont; C Fieschi; N Thomassin; S Rosenzweig; J Harris; S M Holland; R D Schreiber; J L Casanova
Journal:  Science       Date:  2001-07-13       Impact factor: 47.728

6.  STAT1 inhibits liver fibrosis in mice by inhibiting stellate cell proliferation and stimulating NK cell cytotoxicity.

Authors:  Won-Il Jeong; Ogyi Park; Svetlana Radaeva; Bin Gao
Journal:  Hepatology       Date:  2006-12       Impact factor: 17.425

7.  The essential involvement of cross-talk between IFN-gamma and TGF-beta in the skin wound-healing process.

Authors:  Yuko Ishida; Toshikazu Kondo; Tatsunori Takayasu; Yoichiro Iwakura; Naofumi Mukaida
Journal:  J Immunol       Date:  2004-02-01       Impact factor: 5.422

8.  Phosphorylation of the Stat1 transactivation domain is required for full-fledged IFN-gamma-dependent innate immunity.

Authors:  Louisa Varinou; Katrin Ramsauer; Marina Karaghiosoff; Thomas Kolbe; Klaus Pfeffer; Mathias Müller; Thomas Decker
Journal:  Immunity       Date:  2003-12       Impact factor: 31.745

Review 9.  Molecular regulation of vascular smooth muscle cell differentiation in development and disease.

Authors:  Gary K Owens; Meena S Kumar; Brian R Wamhoff
Journal:  Physiol Rev       Date:  2004-07       Impact factor: 37.312

10.  Epidermal β-catenin activation remodels the dermis via paracrine signalling to distinct fibroblast lineages.

Authors:  Beate M Lichtenberger; Maria Mastrogiannaki; Fiona M Watt
Journal:  Nat Commun       Date:  2016-02-03       Impact factor: 14.919

View more
  3 in total

1.  Regulator of Cell Cycle Protein (RGCC/RGC-32) Protects against Pulmonary Fibrosis.

Authors:  Irina G Luzina; Violeta Rus; Virginia Lockatell; Jean-Paul Courneya; Brian S Hampton; Rita Fishelevich; Alexander V Misharin; Nevins W Todd; Tudor C Badea; Horea Rus; Sergei P Atamas
Journal:  Am J Respir Cell Mol Biol       Date:  2022-02       Impact factor: 7.748

2.  Comprehensive analysis of lncRNA and miRNA expression profiles and ceRNA network construction in negative pressure wound therapy.

Authors:  Jie Wu; Yong Qin; Zhirui Li; Jiantao Li; Litao Li; Sheng Tao; Daohong Liu
Journal:  Ann Transl Med       Date:  2021-09

3.  Developing immortal cell lines from Xenopus embryos, four novel cell lines derived from Xenopus tropicalis.

Authors:  Gary J Gorbsky; John R Daum; Hem Sapkota; Katja Summala; Hitoshi Yoshida; Constantin Georgescu; Jonathan D Wren; Leonid Peshkin; Marko E Horb
Journal:  Open Biol       Date:  2022-07-06       Impact factor: 7.124

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.